Lydall Inc (LDL)

62.09  +0.01 (+0.02%)

After market: 62.09 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to LDL. LDL was compared to 132 industry peers in the Machinery industry. LDL has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, LDL is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

In the past year LDL was profitable.

1.2 Ratios

Industry RankSector Rank
ROA -0.07%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 1.94%
PM (TTM) -0.07%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

There is no outstanding debt for LDL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

LDL has an Altman-Z score of 3.11. This indicates that LDL is financially healthy and has little risk of bankruptcy at the moment.
LDL has a Debt/Equity ratio of 0.91. This is a neutral value indicating LDL is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Altman-Z 3.11
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

LDL has a Current Ratio of 1.95. This is a normal value and indicates that LDL is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.48 indicates that LDL should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.48

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1900.00% over the past year.
The Revenue has grown by 16.23% in the past year. This is quite good.
Measured over the past years, LDL shows a small growth in Revenue. The Revenue has been growing by 7.81% on average per year.
EPS 1Y (TTM)1900%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q285.19%
Revenue 1Y (TTM)16.23%
Revenue growth 3Y3.04%
Revenue growth 5Y7.81%
Revenue growth Q2Q51.71%

3.2 Future

LDL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 406.52% yearly.
Based on estimates for the next years, LDL will show a quite strong growth in Revenue. The Revenue will grow by 11.38% on average per year.
EPS Next Y9392%
EPS Next 2Y939.47%
EPS Next 3Y541.91%
EPS Next 5Y406.52%
Revenue Next Year18.7%
Revenue Next 2Y11.55%
Revenue Next 3Y11.26%
Revenue Next 5Y11.38%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 68.99 indicates a quite expensive valuation of LDL.
Compared to an average S&P500 Price/Earnings ratio of 24.92, LDL is valued quite expensively.
LDL is valuated quite expensively with a Price/Forward Earnings ratio of 29.27.
When comparing the Price/Forward Earnings ratio of LDL to the average of the S&P500 Index (21.49), we can say LDL is valued slightly more expensively.
Industry RankSector Rank
PE 68.99
Fwd PE 29.27

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.25

4.3 Compensation for Growth

LDL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LDL's earnings are expected to grow with 541.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y939.47%
EPS Next 3Y541.91%

0

5. Dividend

5.1 Amount

LDL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Lydall Inc

NYSE:LDL (9/30/2021, 7:04:00 PM)

After market: 62.09 0 (0%)

62.09

+0.01 (+0.02%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.12B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 68.99
Fwd PE 29.27
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.07%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 1.94%
PM (TTM) -0.07%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.95
Quick Ratio 1.48
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)1900%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y9392%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)16.23%
Revenue growth 3Y3.04%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y